| JXSL2300031 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-02-02 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2400096 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-10-18 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2500013 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-02-21 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200070 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-19 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300122 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-07-14 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSB2101064 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-10-12 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JXSS2300077 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-09-08 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2500027 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-22 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2400098 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-10-18 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSL2101099 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-08-19 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYSB2500039 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2025-02-15 | | Astrazeneca Uk Ltd | | | view |
| JXSL2200085 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-06-14 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYSB2300055 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-03-22 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200177 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-09-10 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSS2300078 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-09-08 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2500028 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-22 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2400066 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-08-16 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSB2200046 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JXSB2101044 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-08-09 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JYSB2300054 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-03-22 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
